AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21491144
Drug: Technosphere® Insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Technosphere® Insulin (TI) inhalation powder
Trial: 12702132
Drug: Interferon-alfa-2a (IFN)
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alfa-2a (IFN) regimen Group B: 9 MU daily for 2 weeks, 3 MU daily for 22 weeks, then 3 MU three times a week for the last 24 weeks
Trial: 7888013
Drug: Cortisol infusion
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol infusion
Trial: 3831962
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (500 micrograms)
Trial: 3831962
Drug: Intramuscular pentazocine
RxNorm normalized name: Pentazocine
DrugBank: Pentazocine (DB00652)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular pentazocine (30 mg)
Trial: 8138651
Drug: Intramuscular pentazocine
RxNorm normalized name: Pentazocine
DrugBank: Pentazocine (DB00652)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular pentazocine
Trial: 30312799
Drug: Oral TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral TXA (1 g given 2 hours before incision, repeated at 3 hours and 6 hours postoperatively)
Trial: 30312799
Drug: IV TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV TXA (1 g administered 10 minutes before incision, repeated at 3 hours and 6 hours postoperatively)
Trial: 20427749
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D (up to 40,000 IU/day for 28 weeks, then 10,000 IU/day for 12 weeks, followed by 0 IU/day) with calcium (1,200 mg/day)
Trial: 20427749
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D (up to 40,000 IU/day)
Trial: 20427749
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not receiving high-dose vitamin D)
Trial: 16095500
Drug: Donor antibody
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donor antibody titer
Trial: 12360162
Drug: COER-verapamil hydrochloride
RxNorm normalized name: Verapamil Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COER-verapamil hydrochloride (240 mg titrated to 360 mg)
Trial: 12360162
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg titrated to 20 mg)
Trial: 15047641
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg titrated to 100 mg)
Trial: 7013303
Drug: Metoclopramide (cerucal,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (cerucal, 3 x 10 mg p.o.)
Trial: 31743809
Drug: CHO +
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO + Gln (Gln 20 g/d for 6 d and maltodextrin 8%/200 mL for 20 min)
Trial: 30651194
Drug: Subacromial injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial injection (SA)
Trial: 28728560
Drug: Patient-oriented education
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-oriented education and medication management intervention
Trial: 26469896
Drug: Amiodarone therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone therapy group (n = 122 patients)
Trial: 26469896
Drug: Metoprolol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol therapy group (n = 129 patients)
Trial: 19800193
Drug: CRT ON
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRT ON (active treatment)
Trial: 19800193
Drug: CRT OFF
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRT OFF (control treatment)
Trial: 16950955
Drug: Cocoa husk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa husk supplement
Trial: 10899847
Drug: Vaccine lot
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine lot E005
Trial: 10899847
Drug: Vaccine lot
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine lot E003
Trial: 10899847
Drug: Vaccine lot
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine lot E005 and E003
Trial: 8101082
Drug: Broxaterol (B)
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol (B) at 0.75 mg
Trial: 8101082
Drug: Broxaterol (B)
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol (B) at 1.25 mg
Trial: 8101082
Drug: Broxaterol (B)
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol (B) at 2.50 mg
Trial: 8101082
Drug: Broxaterol (B)
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol (B) at 1.25 mg, 3 times a day for 1 month
Trial: 3794304
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg atropine sulfate
Trial: 6113682
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg pirenzepine
Trial: 31550941
Drug: Specific BTK
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific BTK inhibitors
Trial: 26307162
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose bacillus Calmette‐Guérin (40 mg)
Trial: 26307162
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose bacillus Calmette‐Guérin (80 mg)
Trial: 24396757
Drug: Diclofenac 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1.0 mg/kg
Trial: 17396066
Drug: alpha-Lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-Lipoic acid and acetyl-L-carnitine
Trial: 12162470
Drug: Meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 7.5 mg, 15 mg, 30 mg
Trial: 12162470
Drug: Indomethacin (Indo-ER)
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin (Indo-ER) 75 mg once daily
Trial: 7533343
Drug: FK506/prednisone (double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FK506/prednisone (double therapy)
Trial: 7533343
Drug: FK506/azathioprine/prednisone (triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FK506/azathioprine/prednisone (triple therapy)
Trial: 323086
Drug: Calcium dobesylate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesylate, 250 mg three times a day (period B)
Trial: 31558866
Drug: Ropivacaine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine group (7.5 mg/mL ropivacaine infiltration)
Trial: 31558866
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal saline 5 mL infiltration)
Trial: 29028286
Drug: Doppler-guided goal-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doppler-guided goal-directed fluid therapy (GDFT)
Trial: 28440045
Drug: Lorcaserin 10
RxNorm normalized name: lorcaserin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin 10 mg BID
Trial: 27206567
Drug: Lorcaserin 10
RxNorm normalized name: lorcaserin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin 10 mg QD
Trial: 21795446
Drug: Lorcaserin 10
RxNorm normalized name: lorcaserin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin 10 mg BID and QD
Trial: 16255390
Drug: Group cue-exposure
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cue-exposure program to drug-related stimuli (12 treatment sessions, 3 times weekly)
Trial: 9935221
Drug: Preoperative radio‐chemo‐thermo‐therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative radio‐chemo‐thermo‐therapy (RCTT)
Trial: 9935221
Drug: Radio‐chemo‐therapy (RCT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radio‐chemo‐therapy (RCT) without hyperthermia (control group)
Trial: 7778631
Drug: Tocolysis (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocolysis (intravenous magnesium sulfate and/or oral or subcutaneous beta-sympathomimetics)
Trial: 7778631
Drug: Short-term intravenous
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term intravenous magnesium alone
Trial: 6985697
Drug: Molsidomine (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (0.03 mg/kg IV) during exercise-induced angina
Trial: 6985697
Drug: Molsidomine (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (0.03 mg/kg IV) during pacing-induced angina
Trial: 6985697
Drug: Molsidomine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (2 mg three times daily)
Trial: 31221197
Drug: ML-Adaptive Boosting
RxNorm normalized name: BOOST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ML-Adaptive Boosting
Trial: 31221197
Drug: ML-random forest
RxNorm normalized name: Fortesta
DrugBank: Testosterone (DB00624)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ML-random forest
Trial: 31221197
Drug: ML-adaptive boosting
RxNorm normalized name: BOOST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ML-adaptive boosting
Trial: 31221197
Drug: ML-Markov chain
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ML-Markov chain Monte Carlo generalized linear mixed model
Trial: 26433456
Drug: GMT 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GMT 2.0 treatment
Trial: 19117888
Drug: Monthly parenting
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly parenting newsletter (12 issues) containing information on emotional development, parent-child interaction, and play.
Trial: 16009958
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy plus two 5-day chemotherapy courses (fluorouracil 350 mg/m2/d and leucovorin 20 mg/m2/d) in the first and fifth week of RT
Trial: 16009958
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy plus four postoperative chemotherapy courses
Trial: 16009958
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy and chemotherapy plus postoperative chemotherapy
Trial: 11888223
Drug: Hypnosis (standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnosis (standardized eight-session hypnosis treatment)
Trial: 11888223
Drug: Relaxation (standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation (standardized eight sessions of Jacobson's relaxation treatment)
Trial: 2085082
Drug: Propofol alone
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol alone (12‐15 mg/kg/h)
Trial: 2085082
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with fentanyl supplementation (6‐9 mg/kg/h)
Trial: 30945124
Drug: Disease-modifying anti-rheumatic
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying anti-rheumatic drugs (DMARDs)
Trial: 24696369
Drug: Stop-smoking medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop-smoking medication
Trial: 24696369
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (preferred by 85.2% of medication users)
Trial: 23643001
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid 10 mg/kg (intravenous injection slowly before skin incision) followed by infusion of normal saline until postoperative 12 hours
Trial: 23643001
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid 10 mg/kg (intravenous injection slowly before skin incision) followed by infusion of tranexamic acid 1 mg/(kg·h) until postoperative 12 hours
Trial: 19998582
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (Acnez)
Trial: 15140569
Drug: Psychometric assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychometric assessment after EMDR treatment
Trial: 11796084
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of albendazole (400 mg) and praziquantel (40 mg/kg)
Trial: 9494455
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics plus intranasal beclomethasone (336 micrograms/day)
Trial: 9494455
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics plus intranasal placebo
Trial: 10303911
Drug: Mass mammography
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass mammography screening (specific details on dosage and duration not available)
Trial: 27621414
Drug: Syringes (0.2‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syringes (0.2‐ and 0.5‐mL increments)
Trial: 27621414
Drug: Overall dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall dosing error
Trial: 22122880
Drug: Tapering of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering of daytime benzodiazepines
Trial: 43682
Drug: 90% Alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90% Alcohol (10-6 ml)
Trial: 24659797
Drug: Ponesimod 20
RxNorm normalized name: ponesimod 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponesimod 20 mg
Trial: 24659797
Drug: Ponesimod 10
RxNorm normalized name: ponesimod 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponesimod 10 mg
Trial: 24659797
Drug: Ponesimod 40
RxNorm normalized name: ponesimod
DrugBank: Ponesimod (DB12016)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ponesimod 40 mg
Trial: 29024325
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg p-synephrine
Trial: 29024325
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg p-synephrine
Trial: 29024325
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg p-synephrine
Trial: 20809735
Drug: Biodegradable cages
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biodegradable cages (70/30 poly(l‐lactide‐co‐d,l‐lactide) (PLDLA))
Trial: 15585598
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion (Epi) during hyperinsulinemic euglycemic clamp studies
Trial: 15585598
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion (Epi)
Trial: 10996882
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus group therapy (TG+)
Trial: 10996882
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone (TG-)
Trial: 8629922
Drug: Bolus intrathecal
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus intrathecal injection of 50 micrograms baclofen
Trial: 1309633
Drug: PI regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PI regimen (cisplatin 80 mg/m2 dl and ifosfamide 2 g/m2 d 1, 2, 3, q 3‐4 wks)
Trial: 1309633
Drug: PV regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PV regimen (cisplatin 80 mg/m2 d 1 and vindesine 3 mg/m2 d 1, 8, 15, q 3‐4 wks)
Trial: 6152804
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg megestrol acetate and 5 mg estradiol valerate
Trial: 6152804
Drug: Microencapsulated megestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microencapsulated megestrol compound
Trial: 20691834
Drug: n‐3 polyunsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 polyunsaturated fatty acids (1 g/d)
Trial: 19026871
Drug: 1.8 mL
RxNorm normalized name: insulin pump syringe, 1.8 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 mL of 1% diphenhydramine with 1:100,000 epinephrine
Trial: 20307730
Drug: 1.8 mL
RxNorm normalized name: insulin pump syringe, 1.8 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 mL of 2% lidocaine with 1:100,000 epinephrine
Trial: 19026871
Drug: 3.6 mL
RxNorm normalized name: ALCOHOL 2.7 mL in 3.6 mL TOPICAL CLOTH [hand sanitizers]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 mL of 2% lidocaine with 1:100,000 epinephrine combined with 1% diphenhydramine with 1:100,000 epinephrine
Trial: 15781499
Drug: General Anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General Anesthesia (GA) with fentanyl (7-15 microg/kg) and morphine infusion
Trial: 15781499
Drug: High Thoracic
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Thoracic Epidural Anesthesia (HTEA) with fentanyl (5-7 microg/kg) and epidural infusion of ropivacaine 0.2% and fentanyl 2 microg/mL until postoperative Day 3
Trial: 12519833
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (0.625 mg/d orally)
Trial: 1346410
Drug: Cyclosporin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (5 mg/kg per day for 12 weeks)
Trial: 29960287
Drug: Qinbei Qingfei
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qinbei Qingfei Yiqi (QBQFYQ) granules plus usual treatment
Trial: 19303966
Drug: Low-dose supplemental
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose supplemental vitamins E plus C
Trial: 19303966
Drug: Medium-dose supplemental
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose supplemental vitamins E plus C
Trial: 19303966
Drug: High-dose supplemental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose supplemental vitamins E plus C
Trial: 15156934
Drug: Cranberry supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry supplement (400 mg, 3 times a day for 4 weeks)
Trial: 29885904
Drug: Midazolam 5
RxNorm normalized name: midazolam 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 5 mg
Trial: 27817037
Drug: Total recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total recombinant follicle‐stimulating hormone (rFSH) dose
Trial: 24053627
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid administered 24 hours after endoscopic procedure for 14 days
Trial: 19820872
Drug: Vaginal estriol
RxNorm normalized name: estriol Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estriol therapy for 14 days
Trial: 19820872
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no estriol therapy)
Trial: 9227927
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b combined with cytarabine (20 mg per square meter per day for 10 days, plus hydroxyurea 50 mg per kilogram per day)
Trial: 9227927
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b alone (plus hydroxyurea 50 mg per kilogram per day)
Trial: 7954535
Drug: Furosemide, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide, 25 mg/day
Trial: 7954535
Drug: Torasemide, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torasemide, 10 mg/day
Trial: 3664553
Drug: Aspirin with
RxNorm normalized name: Bayer Aspirin with Calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin with codeine
Trial: 28058750
Drug: Evogliptin 5
RxNorm normalized name: alogliptin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evogliptin 5 mg after 52 weeks
Trial: 28058750
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg after 52 weeks
Trial: 26232505
Drug: Galactooligosaccharide (1.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galactooligosaccharide (1.7 g)